Defender Capital’s Pfizer PFE Stock Holding History

Defender Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$403K	Hold	16,735	–	–	0.13%	29
2026 Q1	$470K	Hold	16,735	–	–	0.17%	22
2025 Q4	$417K	Buy	+16,735	New	+$422K	0.14%	27
2025 Q3	–	Sell	-16,735	Closed	-$406K	–	27
2025 Q2	$406K	Buy	16,735 +360	+2%	+$8.4K	0.14%	29
2025 Q1	$411K	Sell	16,375 -560	-3%	-$14.7K	0.16%	27
2024 Q4	$449K	Sell	16,935 -1,000	-6%	-$27.1K	0.17%	25
2024 Q3	$519K	Hold	17,935	–	–	0.17%	23
2024 Q2	$502K	Sell	17,935 -20	-0.1%	-$551	0.17%	22
2024 Q1	$498K	Buy	17,955 +20	+0.1%	+$555	0.17%	20
2023 Q4	$516K	Hold	17,935	–	–	0.18%	23
2023 Q3	$595K	Hold	17,935	–	–	0.22%	20
2023 Q2	$658K	Buy	+17,935	New	+$698K	0.23%	21
2022 Q1	–	Sell	-12,935	Closed	-$764K	–	40
2021 Q4	$764K	Buy	12,935 +2,697	+26%	+$134K	0.24%	21
2021 Q3	$440K	Buy	10,238 +38	+0.4%	+$1.68K	0.14%	30
2021 Q2	$399K	Buy	+10,200	New	+$397K	0.13%	28

Other funds holding PFE

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

ORIO

Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

Defender Capital's PFE Position: Q2 2026 in Review

Defender Capital held its Pfizer (PFE) position steady in Q2 2026 at 16,735 shares worth $403K. The position accounts for 0.13% of the portfolio, ranked #29.

Defender Capital first reported a position in PFE in Q2 2021 and has held it in 15 quarters since. The position peaked at $764K in Q4 2021. 490 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Defender Capital held 16,735 shares of Pfizer worth $403K as of Q2 2026.
Defender Capital left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.13% of Defender Capital's portfolio in Q2 2026, its #29 holding.
Defender Capital first reported a position in Pfizer in Q2 2021 and has held it in 15 quarters since.
Defender Capital's Pfizer position peaked at $764K in Q4 2021.
490 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Defender Capital's 13F filing for Q2 2026, filed 9 Jul 2026.